MedTrace Logo

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back Pain

NCT01570127 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2012-04-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether acupuncture treatment(Individualized \& Standardized Acupuncture) is more effective than control (sham acupuncture or no treatment) and also whether individualized acupuncture is more effective than standardized acupuncture.

Conditions

  • Low Back Pain

Interventions

PROCEDURE

Individualized Acupuncture

The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions)

PROCEDURE

Standardized Acupuncture

The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions) 8 Acupuncture points, GV4, GV3, BL24(bilateral), BL25(bilateral) and GB30(bilateral) were used for all the patients assigned to this group. Sterile Stainless Steel(25mm x 40mm) disposable acupuncture needles manufactured by Dong-Bang Acupuncture Co.(Korea) were used.

PROCEDURE

Sham Acupuncture

The treatment was applied twice a week for 6 weeks(12sessions). The sham acupuncture was applied on the 8 same acupuncture points as in the standardized acupuncture group, GV4, GV3, BL24(bilateral), BL25(bilateral) and GB30(bilateral). Each session was 20 minutes long.

OTHER

Waiting

No interventions were applied to the patients in this group.

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Gachon University Gil Medical Center

    collaborator OTHER

  • Dongwoo Nam

    lead OTHER

Principal Investigators

  • Jae-Dong Lee, Ph.D · Kyunghee University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-08-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01570127 on ClinicalTrials.gov